Cargando…
Insect protease inhibitors; promising inhibitory compounds against SARS-CoV-2 main protease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has adversely affected global health since its emergence in 2019. The lack of effective treatments prompted worldwide efforts to immediately develop therapeutic strategies agains...
Autores principales: | Hemmati, Seyed Ali, Tabein, Saeid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755557/ https://www.ncbi.nlm.nih.gov/pubmed/35051855 http://dx.doi.org/10.1016/j.compbiomed.2022.105228 |
Ejemplares similares
-
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020) -
Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021) -
Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022) -
Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022) -
In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2
por: Khan, Saba, et al.
Publicado: (2023)